MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma

MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma

Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its resistance to the current treatment regimen. Over the last few decades, a significant amount of new molecular and genetic findings has been reported regarding factors contributing to GBM’s development into a lethal p...

Full description

Bibliographic Details
Main Authors:	Isra Saif Eldin Eisa Sati, Ishwar Parhar
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	International Journal of Molecular Sciences
Subjects:	RB P53 PI3K EGFR MGMT TMZ
Online Access:	https://www.mdpi.com/1422-0067/22/24/13550

Similar Items

BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death
by: Huey-Jiun Ko, et al.
Published: (2022-12-01)

Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
by: Qiong Wu, et al.
Published: (2023-10-01)

NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition
by: Cheng-Yu Tsai, et al.
Published: (2021-05-01)

Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR
by: Sabrina Staffieri, et al.
Published: (2023-08-01)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
by: Haoyue Xu, et al.
Published: (2023-12-01)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
by: Milan Teraiya, et al.
Published: (2023-04-01)

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
by: Lee YY, et al.
Published: (2018-04-01)

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
by: Junhu Zhou, et al.
Published: (2023-05-01)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
by: Arne Christians, et al.
Published: (2019-10-01)

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
by: Bryan G. Harder, et al.
Published: (2019-11-01)

Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
by: Konstantinos Gousias, et al.
Published: (2022-02-01)

Clinical Implications of Promoter Hypermethylation in RASSF1A and MGMT in Retinoblastoma
by: Kwong Wai Choy, et al.
Published: (2005-03-01)

The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients
by: Heena Sareen, et al.
Published: (2020-07-01)

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma
by: Miyuki Uno, et al.
Published: (2011-01-01)

Two Cases of TKI-resistant Small Cell Lung Cancer Transformation  in Advanced Adenocarcinoma and Literature Review
by: Jieqiong WU, et al.
Published: (2022-11-01)

Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide Response
by: Justin Bo-Kai Hsu, et al.
Published: (2021-10-01)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
by: Woong-Jai Won, et al.
Published: (2019-01-01)

Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01)

Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR
by: Maurizio Salvati, et al.
Published: (2020-02-01)

Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer
by: Clémence Basse, et al.
Published: (2023-02-01)

Cell Cycle and Apoptosis
by: Bruna Pucci, et al.
Published: (2000-07-01)

Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
by: Anna Kirstein, et al.
Published: (2021-06-01)

Aberrant Expression of Rb and pRb-780, pRb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance
by: Yunlong DONG, et al.
Published: (2017-05-01)

Survival Outcomes and Prognostic Factors in Glioblastoma
by: Nicholas F. Brown, et al.
Published: (2022-06-01)

Glutathione S-Transferase M3 Is Associated with Glycolysis in Intrinsic Temozolomide-Resistant Glioblastoma Multiforme Cells
by: Shu-Yu Cheng, et al.
Published: (2021-06-01)

Implication of Lactucopicrin in Autophagy, Cell Cycle Arrest and Oxidative Stress to Inhibit U87Mg Glioblastoma Cell Growth
by: Rossella Rotondo, et al.
Published: (2020-12-01)

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
by: Dong-Yu Wang, et al.
Published: (2019-01-01)

CELL CYCLE REGULATING GENES AND THEIR PROTEIN EXPRESSION IN SQUAMOUS CELL CARCINOMA OF THE LARYNX AND HYPOPHARYNX
by: Metka Volavšek, et al.
Published: (2002-12-01)

Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment
by: Yongxia Chen, et al.
Published: (2023-12-01)

Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
by: Luca X. Zampieri, et al.
Published: (2021-11-01)

Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma
by: Chun-Man Yuen, et al.
Published: (2023-10-01)

Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
by: Bianca Maria Scicchitano, et al.
Published: (2018-09-01)

Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
by: Lei Dong, et al.
Published: (2022-10-01)

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
by: Koji eYoshimoto, et al.
Published: (2012-12-01)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
by: Jonas Feldheim, et al.
Published: (2022-05-01)

Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells
by: Remi Weber, et al.
Published: (2024-01-01)

Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy
by: Zhen Wang, et al.
Published: (2022-07-01)

Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
by: Sicheng Wan, et al.
Published: (2023-05-01)

Isoginkgetin—A Natural Compound to Control U87MG Glioblastoma Cell Growth and Migration Activating Apoptosis and Autophagy
by: Maria Antonietta Oliva, et al.
Published: (2022-11-01)

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
by: Ji-Young Yoo, et al.
Published: (2021-07-01)